| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | +0.5% | +39.4% |
| Cost of Revenue | $1.3M | -2.6% | +14.4% |
| Gross Profit | $840K | +5.8% | +110.4% |
| R&D Expense | $39K | -37.2% | +162.5% |
| SG&A Expense | $4.7M | -34.3% | +244.0% |
| Operating Income | -$5.0M | +31.0% | -239.6% |
| Interest Expense | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $64.3M | +65.1% | +3713.4% |
| Short-term Investments | $16.8M | — | — |
| Accounts Receivable | $310K | +78.5% | +287.4% |
| Inventory | $3.1M | +93.8% | +114.6% |
| Current Assets | $91.7M | +117.2% | +1930.1% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.4M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | -$12.5M | — | — |
| Financing Cash Flow | $84.4M | — | — |
| Free Cash Flow | -$12.9M | — | — |
| — |
| -100.0% |
| Net Income | $1.6M | +123.0% | +174.8% |
| EPS (Basic) | $0.05 | +115.6% | +116.7% |
| EPS (Diluted) | $0.05 | +115.6% | +116.7% |
| $113.1M |
| +115.6% |
| +361.1% |
| Current Liabilities | $5.9M | +622.2% | +194.0% |
| Total Liabilities | $7.1M | +520.0% | +33.3% |
| Stockholders' Equity | $106.0M | +106.6% | +451.4% |